ELAN trial post-hoc analysis: Early DOAC treatment after ischemic strokes was not associated with a higher rate of adverse events, especially sICH, regardless of infarct size group. Persons with major stroke seem to benefit most (OR 0.52 (0.21 to 1.18)). ja.ma/45TrYEj

Honored to join the 2024 Asian Stroke Summer School. It is inspiring to meet so many colleagues from India and Southeast Asia who are fully dedicated to enhancing stroke care. Thanks to PN Sylaja, Urs Fischer Urs Martin Fischer, and Jan Gralla for leading this great initiative

Stroke Research Center Bern scaling up the success of stroke treatment globally 🌏 Universität Bern @uniofbern Faculty of Medicine, University of Bern Clinical Neuroscience Bern SCAN Neurorad Bern Insel Gruppe 🚨Insel Notfall News Bern🆘 Stadt Bern Vascular Neurology Notes European Stroke Org World Stroke Org

Hands-on training to #GTFVO at the #2024 #Asian #Stroke Summer School in Trivandrum, Kerala! 💪🧠🫀 asss2024.com

That's the energy! #FightStroke #GTFVO 2024 Asian Stroke Summer School

Early anticoagulation in ischaemic stroke patients with haemorrhagic transformation? Stroke Research Center Bern

🚨 New ELAPSE Trial Site Alert! 🚨 The Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne has officially opened today as the newest site in Switzerland for the ELAPSE trial and is now recruiting patients! Stroke Research Center Bern Lorenz Räber, MD PhD Urs Martin Fischer David Seiffge

Elliot Pressman MaxMokinMD Kunal Vakharia Journal of Neurosurgery University of South Florida Neurosurgery Results to me seem consistent w/ SWITCH. SWITCH primary outcome was mRS 5-6. mRS 4 seen as good outcome. You are underpowered to find sig benefit for mRS 5-6 (as was SWITCH with 2x your n) but that does not r/o an effect which your Grotta bars suggest Urs Martin Fischer

After how many years will people with an asymptomatic condition gain a treatment benefit when compared with people managed conservatively? Check our decision-making paper, published in Stroke! Johannes Goldberg Jürgen Beck Johannes Kaesmacher Insel Gruppe

Join me in this action, changes do not come on it’s own World Stroke Org European Stroke Org WorldStrokeCampaign World Health Organization (WHO) World Federation of Neurology (WFN) European Academy of Neurology

Starkniederschläge und Worst-Case Szenarien Interview im heutigen SRF News Tagesgespräch zur Einordnung der intensiven Gewitter dieses Sommers und zu unserer neuen Forschung am D-USYSETH Zürich der @ETH zu Worst-Case Szenarien für Wetterextreme im Klimawandel srf.ch/audio/tagesges…

Timing of Anticoagulation in Relation to Cerebral Infarct Severity Across a range of stroke severity, early initiation of direct oral anticoagulants was safe in patients with recent stroke and atrial fibrillation. jwat.ch/4dDPW8Z #NeuroTwitter #stroke Seemant Chaturvedi

Many thanks for discussing our ELAN substudy!

Perfusion Abnormalities on 24-Hour Perfusion Imaging in Patients With Complete Endovascular Reperfusion | Stroke ahajournals.org/doi/abs/10.116…

Interresting paper: how to treat „breakthrough“ stroke despite anticoagulation in patients with AFib? DOACs best, changing/switching is just psychology. Still high recurrence rate, better treatments needed ELAPSE Urs Martin Fischer Lorenz Räber, MD PhD Stroke Research Center Bern Christian H Nolte

What a fantastic speaker line up for Stroke Grand Rounds this fall UTHealthNeurosciences We are SUPER EXCITED 🥳

Attending #ESCCongress in #London? Come by our booth to find out how the #strokecommunity fights #CVD and how #together we improve patients lives. We are looking forward to discussing with you.

Resultate einer internationalen intravaskulären Studie geleitet von der Uniklinik für Kardiologie der #InselGruppe & Universität Bern, wurden gestern auf dem European Society of Cardiology Kongress in London präsentiert & im European Heart Journal veröffentlicht: inselgruppe.ch/de/aktuell/det…

Stroke Winter School in Bern - a living legend!